Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY (Unaudited)

v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Purchase of Arbuz shares
Purchase of ReKassa shares
Total equity attributable to the shareholders'
Total equity attributable to the shareholders'
Purchase of Arbuz shares
Total equity attributable to the shareholders'
Purchase of ReKassa shares
Common Stock
Additional paid in capital
Retained earnings
Retained earnings
Purchase of Arbuz shares
Retained earnings
Purchase of ReKassa shares
Accumulated other comprehensive loss
Non- controlling interest
Non- controlling interest
Purchase of Arbuz shares
Non- controlling interest
Purchase of ReKassa shares
Beginning balance (in shares) at Mar. 31, 2022             59,542,212,000                
Equity, beginning of period at Mar. 31, 2022 $ 546,608     $ 553,603     $ 59 $ 174,745 $ 441,924     $ (63,125) $ (6,995)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Stock based compensation 6,801     6,801       6,801              
Sale of Freedom UA shares 0                            
Capital contributions 677     677       677              
Acquisition of insurance companies (26,588)     (26,588)       (26,588)              
Foreign currency translation adjustments, net of tax effect 5,316     5,316               5,316      
Other comprehensive reserve 2,234     2,234               2,234      
Net income/(loss) 86,283     87,327         87,327       (1,044)    
Ending balance (in shares) at Sep. 30, 2022             59,542,212,000                
Equity, end of period at Sep. 30, 2022 621,331     629,370     $ 59 155,635 529,251     (55,575) (8,039)    
Beginning balance (in shares) at Jun. 30, 2022             59,542,212,000                
Equity, beginning of period at Jun. 30, 2022 606,918     615,907     $ 59 152,532 502,989     (39,673) (8,989)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Stock based compensation 3,103     3,103       3,103              
Sale of Freedom UA shares 0                            
Capital contributions 0                            
Exercise of options 0                            
Foreign currency translation adjustments, net of tax effect (16,663)     (16,663)               (16,663)      
Other comprehensive reserve 761     761               761      
Net income/(loss) 27,212     26,262         26,262       950    
Ending balance (in shares) at Sep. 30, 2022             59,542,212,000                
Equity, end of period at Sep. 30, 2022 $ 621,331     629,370     $ 59 155,635 529,251     (55,575) (8,039)    
Beginning balance (in shares) at Mar. 31, 2023 59,659,191           59,659,191,000                
Equity, beginning of period at Mar. 31, 2023 $ 770,736     777,285     $ 59 164,162 647,064     (34,000) (6,549)    
Equity, beginning of period (Cumulative adjustment from adoption of ASC 326) at Mar. 31, 2023 (22,772)     (22,772)         (22,772)            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Stock based compensation 2,264     2,264       2,264              
Disposal of FF Ukraine 0     (6,549)         (6,549)       6,549    
Purchase of subsidiary shares   $ 9,097 $ 256   $ 5,457 $ 0       $ 5,457 $ 0     $ 3,640 $ 256
Foreign currency translation adjustments, net of tax effect (31,693)     (31,693)               (31,693)      
Other comprehensive reserve 3,143     3,143               3,143      
Net income/(loss) $ 183,400     183,949         183,949       (549)    
Ending balance (in shares) at Sep. 30, 2023 59,659,191           59,659,191,000                
Equity, end of period at Sep. 30, 2023 $ 914,431     911,084     $ 59 166,426 807,149     (62,550) 3,347    
Beginning balance (in shares) at Jun. 30, 2023             59,659,191,000                
Equity, beginning of period at Jun. 30, 2023 825,736     822,277     $ 59 165,395 691,302     (34,479) 3,459    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Stock based compensation 1,031     1,031       1,031              
Capital contributions 0                            
Acquisition of insurance companies 0                            
Purchase of subsidiary shares     $ 256     $ 0         $ 0       $ 256
Foreign currency translation adjustments, net of tax effect (29,933)     (29,933)               (29,933)      
Other comprehensive reserve 1,862     1,862               1,862      
Net income/(loss) $ 115,479     115,847         115,847       (368)    
Ending balance (in shares) at Sep. 30, 2023 59,659,191           59,659,191,000                
Equity, end of period at Sep. 30, 2023 $ 914,431     $ 911,084     $ 59 $ 166,426 $ 807,149     $ (62,550) $ 3,347